G1 Therapeutics Inc (NAS:GTHX)
$ 7.15 0 (0%) Market Cap: 377.22 Mil Enterprise Value: 364.45 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 34/100

Q4 2021 G1 Therapeutics Inc Earnings Call Transcript

Feb 23, 2022 / 01:30PM GMT
Release Date Price: $9.76 (+1.24%)
Operator

Good morning, ladies and gentlemen, and welcome to G1 Therapeutics Fourth Quarter 2021 Financial Results Conference Call. (Operator Instructions)

I would now like to turn the conference over to your host today, Will Roberts, Head of Corporate Communications. Sir, please go ahead.

William C. Roberts
G1 Therapeutics, Inc. - VP of IR & Corporate Communications

Thanks, Joanna. Good morning, everyone, and welcome to the G1 conference call to discuss our fourth quarter 2021 financial results and business update. The press release on these financial results was issued this morning and can be found in the News section of our corporate website, g1therapeutics.com.

On this morning's call, the team will provide a business overview of the fourth quarter and full year of 2021 including an update on our clinical programs and our commercial progress in that period with COSELA, which is approved by the U.S. Food and Drug Administration to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot